Development of Genetic and Stem Cell Approaches in the Cochlear Lateral Wall

耳蜗外侧壁遗传和干细胞方法的发展

基本信息

批准号：
7884956
负责人：
E Bryan Crenshaw
金额：
$ 20.56万
依托单位：
CHILDREN'S HOSP OF PHILADELPHIA
依托单位国家：
美国
项目类别：
财政年份：
2010
资助国家：
美国
起止时间：
2010-04-01 至 2012-03-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7884956
关键词：
Agonist Animal Model Biological Biology Cell Therapy Cells Communities Complex Data Development Differentiation and Growth Enhancers Ensure Environment Fibroblast Growth Factor Functional disorder Funding Gene Expression Genes Genetic Goals Grant Growth Growth Factor Growth and Development function Hearing Hematopoietic stem cells Knowledge Labyrinth Lateral Lead Ligaments Maintenance Mesenchyme Metabolism Modeling Molecular Mouse Strains Mus Mutant Strains Mice Mutation Nature Noise Phenotype Physiology Population Presbycusis Regulation Research Research Personnel Role Sensorineural Hearing Loss Signal Pathway Signal Transduction Stem Cell Development Stem cells Stimulus Stria Vascularis Structure System Techniques Testing Tetanus Helper Peptide Tetracyclines Tissues Trans-Activators Transgenic Animals Transgenic Mice Work age related base deafness design enhanced green fluorescent protein hearing impairment in vivo insight mouse model mutant prevent public health relevance repaired research study response stem cell therapy tool

项目摘要

DESCRIPTION (provided by applicant): The lateral cochlear wall maintains the ionic metabolism necessary for normal cochlear physiology, and disruption of lateral cochlear wall function - by genetic or environmental insults - leads to hearing loss. Despite the importance of this structure, little is known about its normal growth and development, and there are currently no means to repair this structure once it is damaged. Here, we propose to develop genetic and stem cell-based approaches necessary to accelerate research in a component of the lateral wall, the spiral ligament, whose integrity is vital for lateral wall function. The ultimate goal of this proposal is to develop stem cell-based therapies to correct hearing loss in an animal model of spiral ligament dysfunction, the Brn4/Pou3f3 mutant. To effectively implement and optimize the use of stem cells, a fundamental understanding of the basic biology of growth and differentiation of the spiral ligaments is necessary. In particular, knowledge of the cell signaling pathways that support the growth and maintenance of spiral ligament fibrocytes will be key to optimizing stem cell approaches. Therefore, early in the grant-funding period, we propose to characterize the growth factors that normally regulate spiral ligament fibrocytes. Subsequently, once we have developed a working model of stem cell therapy in mice, we can use our knowledge of fibrocyte growth factor regulation to design rational approaches to optimize the targeting and growth of stem cells in the spiral ligament. Additionally, we propose to develop a powerful, versatile genetic tool to express genes, including the relevant growth factors, in the spiral ligament. Using a previously characterized otic enhancer from the Brn4 gene, we will express the Tet- On version of the tetracycline-inducible gene expression system in cochlear fibrocytes. Each of these tools/approaches alone has great potential to enhance our understanding of the development, physiology and function of the spiral ligament. However, in conjunction, these tools/approaches will synergize to accelerate experimentation on the lateral cochlear wall, and optimize our ability to replenish spiral fibrocytes in animal models of hearing loss using stem cell therapy. PUBLIC HEALTH RELEVANCE: Stem cell therapies hold tremendous promise for reconstructing or replacing tissue damaged by genetic or environmental insults. Here, we propose to develop stem cell approaches to reverse damage of the spiral ligament, a structure that is necessary to maintain the proper ionic environment in the inner ear. By developing powerful experimental tools, we will accelerate research that can help to cure or ameliorate hearing loss.

描述（由申请人提供）：耳蜗外侧壁维持正常耳蜗生理机能所需的离子代谢，而遗传或环境损伤对耳蜗外侧壁功能的破坏会导致听力损失。尽管这种结构很重要，但人们对其正常生长和发育知之甚少，而且一旦这种结构受损，目前还没有办法修复。在这里，我们建议开发基于遗传和干细胞的方法，以加速对侧壁组成部分螺旋韧带的研究，螺旋韧带的完整性对于侧壁功能至关重要。该提案的最终目标是开发基于干细胞的疗法，以纠正螺旋韧带功能障碍动物模型（Brn4/Pou3f3 突变体）中的听力损失。为了有效实施和优化干细胞的使用，有必要对螺旋韧带生长和分化的基本生物学有基本的了解。特别是，了解支持螺旋韧带纤维细胞生长和维持的细胞信号通路将是优化干细胞方法的关键。因此，在拨款资助期间的早期，我们建议表征通常调节螺旋韧带纤维细胞的生长因子。随后，一旦我们在小鼠中开发出干细胞治疗的工作模型，我们就可以利用我们对纤维细胞生长因子调节的知识来设计合理的方法来优化干细胞在螺旋韧带中的靶向和生长。此外，我们建议开发一种强大的、多功能的遗传工具来表达螺旋韧带中的基因，包括相关的生长因子。使用先前表征的 Brn4 基因耳增强子，我们将在耳蜗纤维细胞中表达四环素诱导基因表达系统的 Tet-On 版本。这些工具/方法中的每一种都具有巨大的潜力，可以增强我们对螺旋韧带的发育、生理学和功能的理解。然而，结合起来，这些工具/方法将协同加速耳蜗侧壁实验，并优化我们使用干细胞疗法补充听力损失动物模型中螺旋纤维细胞的能力。公共健康相关性：干细胞疗法对于重建或替换因遗传或环境损伤而受损的组织具有巨大的希望。在这里，我们建议开发干细胞方法来逆转螺旋韧带的损伤，螺旋韧带是维持内耳适当离子环境所必需的结构。通过开发强大的实验工具，我们将加速有助于治愈或改善听力损失的研究。